KLRS · CIK 0001754068 · operating
Kalaris Therapeutics, Inc. (KLRS) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $199 million, Kalaris Therapeutics, Inc. is a micro-cap company. The stock currently trades at $10.31, down 1.43% today, with a 52-week range of $2.14–$12.90.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-11.73 | $-11.73 | -541.0% | |
| 2023 | $-1.83 | $-1.83 | +16.8% | |
| 2022 | $-2.20 | $-2.20 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — |